<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03236558</url>
  </required_header>
  <id_info>
    <org_study_id>16/8254</org_study_id>
    <nct_id>NCT03236558</nct_id>
  </id_info>
  <brief_title>The Role of the Thymus in Type I Diabetes.</brief_title>
  <acronym>TregDiab</acronym>
  <official_title>Thymic Generation of Regulatory T Lymphocytes in Type I Diabetes Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centre National de la Recherche Scientifique, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Regulatory T lymphocytes play a major role in the protection from autoimmune pathology.
      Defects in immunosuppression mediated by these cells is therefore suspected to contribute to
      these diseases. This issue has very little been studied in humans.Regulatory T cells
      emigrated from the thymus will be isolated from the blood of patients and healthy controls.
      The repertoire of antigen-receptors will be analysed by high throughput sequencing and its
      diversity estimated using appropriate statistical models borrowed from ecology.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In the thymus of an animal model of type I diabetes, the population of regulatory T cells
      expresses a repertoire of antigen receptors that is approximately ten-fold less diverse than
      that found in mice resistant to autoimmune pathology. Genetic models later showed that this
      reduced diversity was involved in the susceptibility to diabetes. Researchers study the
      diversity of the TCR expressed by regulatory T cells from paediatric type I diabetes patients
      and controls. Regulatory T cells emigrated from the thymus will be isolated from the blood of
      patients and healthy controls. The repertoire of antigen-receptors will be analysed by high
      throughput sequencing and its diversity estimated using appropriate statistical models
      borrowed from ecology.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2018</start_date>
  <completion_date type="Anticipated">February 2019</completion_date>
  <primary_completion_date type="Anticipated">February 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Variability of the diversity of antigen-receptors' repertoires, expressed by regulatory T cells from type I diabetes patients and healthy controls.</measure>
    <time_frame>Day 1</time_frame>
    <description>Treg from the pediatric patients and the control subjects' blood will be isolated by cytometry, the messenger ribonucleic acid (mRNA) of these cells will be isolated, and the analysis of the alpha and beta chains of the TCRs will be carried out by high-throughput sequencing.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ratio between TCR diversities expressed by Treg cells vs. conventional T cells.</measure>
    <time_frame>Day 1</time_frame>
    <description>Treg from the pediatric patients and the control subjects' blood will be isolated by cytometry, the mRNA of these cells will be isolated, and the analysis of the alpha and beta chains of the TCRs will be carried out by high-throughput sequencing.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Type1 Diabetes</condition>
  <arm_group>
    <arm_group_label>Patients with diabetes</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>T1D patients with blood collection</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood collection</intervention_name>
    <description>Ten cc of peripheral blood will be taken from patients and healthy controls as soon as possible after T1D diagnosis of the former.</description>
    <arm_group_label>Patients with diabetes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  type I diabetes patient

          -  having at least one age-matched sibling (healthy control)

        Exclusion Criteria:

          -  other immunopathology

          -  treatment with any anti-inflammatory or immunosuppressive drugs

          -  puberty

          -  legal protection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Claire Le Tallec, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Claire Le Tallec, MD</last_name>
    <phone>5 34 55 85 79</phone>
    <phone_ext>33</phone_ext>
    <email>letallec.c@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Françoise Auriol</last_name>
    <phone>5 67 77 10 95</phone>
    <phone_ext>33</phone_ext>
    <email>auriol.f@chu-toulouse.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHU de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <state>Midi-Pyrénées</state>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Claire Le Tallec, MD</last_name>
      <phone>5 34 55 85 79</phone>
      <phone_ext>33</phone_ext>
      <email>letallec.c@chu-toulouse.fr</email>
    </contact>
    <contact_backup>
      <last_name>Françoise Auriol</last_name>
      <phone>5 67 77 10 95</phone>
      <phone_ext>33</phone_ext>
      <email>auriol.f@chu-toulouse.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Claire Le Tallec, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carole Morin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zeina Ajaltouni, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <reference>
    <citation>Ferreira C, Singh Y, Furmanski AL, Wong FS, Garden OA, Dyson J. Non-obese diabetic mice select a low-diversity repertoire of natural regulatory T cells. Proc Natl Acad Sci U S A. 2009 May 19;106(20):8320-5. doi: 10.1073/pnas.0808493106. Epub 2009 Apr 9.</citation>
    <PMID>19359477</PMID>
  </reference>
  <reference>
    <citation>Thiault N, Darrigues J, Adoue V, Gros M, Binet B, Perals C, Leobon B, Fazilleau N, Joffre OP, Robey EA, van Meerwijk JP, Romagnoli P. Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors. Nat Immunol. 2015 Jun;16(6):628-34. doi: 10.1038/ni.3150. Epub 2015 May 4.</citation>
    <PMID>25939024</PMID>
  </reference>
  <reference>
    <citation>Steffens CM, Al-Harthi L, Shott S, Yogev R, Landay A. Evaluation of thymopoiesis using T cell receptor excision circles (TRECs): differential correlation between adult and pediatric TRECs and naïve phenotypes. Clin Immunol. 2000 Nov;97(2):95-101.</citation>
    <PMID>11027449</PMID>
  </reference>
  <reference>
    <citation>Calder AE, Hince MN, Dudakov JA, Chidgey AP, Boyd RL. Thymic involution: where endocrinology meets immunology. Neuroimmunomodulation. 2011;18(5):281-9. doi: 10.1159/000329496. Epub 2011 Sep 22. Review.</citation>
    <PMID>21952680</PMID>
  </reference>
  <reference>
    <citation>Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol. 2010 Jul;10(7):490-500. doi: 10.1038/nri2785. Epub 2010 Jun 18. Review.</citation>
    <PMID>20559327</PMID>
  </reference>
  <reference>
    <citation>Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract. 2004 May;10(2):307-12.</citation>
    <PMID>15189396</PMID>
  </reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2017</study_first_submitted>
  <study_first_submitted_qc>July 28, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2017</study_first_posted>
  <last_update_submitted>October 25, 2017</last_update_submitted>
  <last_update_submitted_qc>October 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Type 1 diabetes</keyword>
  <keyword>Juvenile diabetes</keyword>
  <keyword>Immune-tolerance</keyword>
  <keyword>Regulatory T lymphocyte</keyword>
  <keyword>Treg</keyword>
  <keyword>TCR</keyword>
  <keyword>Repertoire</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

